| Followers | 65 |
| Posts | 10174 |
| Boards Moderated | 0 |
| Alias Born | 03/29/2015 |
Monday, February 24, 2025 10:07:05 AM
I recall being told here that a conflicts committee had looked into these kinds of allegations and found no issues or at least no conflicts that were being improperly addressed.
To rebut your point, NWBO could publish the minutes of the conflicts committee and other related documents for the committee’s work. Anyone could then presumably prove that the conflicts of interest issue was overblown etc.
Alternatively, if NWBO wants to just get rid of these criticisms altogether but without increasing their transparency, they have another option and one I would prefer they take instead as I will profit from it:
They could always just make darned sure to fully exploit the upcoming MHRA approval milestone for all it’s worth and pull out of every stop to ensure that working and retired retail shareholders fully share in the spoils.
To rebut your point, NWBO could publish the minutes of the conflicts committee and other related documents for the committee’s work. Anyone could then presumably prove that the conflicts of interest issue was overblown etc.
Alternatively, if NWBO wants to just get rid of these criticisms altogether but without increasing their transparency, they have another option and one I would prefer they take instead as I will profit from it:
They could always just make darned sure to fully exploit the upcoming MHRA approval milestone for all it’s worth and pull out of every stop to ensure that working and retired retail shareholders fully share in the spoils.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
